Aurobindo drug receives final approval

Aurobindo Pharma has received final approval for Venlafaxine Hydrochloride tablets 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg from the US Food and Drug Administration. These are generic equivalent of Wythe Pharmaceutical’s Effexor tablets.

The tablets are useful in treatment of major depressive disorder and falls under the therapeutic category of central nervous system. The product would be launched shortly. Aurobindo has a total 114 abbreviated new drug molecule approvals, a release said.